FORGHIERI, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 8.458
EU - Europa 3.738
AS - Asia 1.492
SA - Sud America 103
Continente sconosciuto - Info sul continente non disponibili 14
AF - Africa 11
OC - Oceania 6
Totale 13.822
Nazione #
US - Stati Uniti d'America 8.417
GB - Regno Unito 1.346
IT - Italia 613
SE - Svezia 557
SG - Singapore 454
CN - Cina 415
HK - Hong Kong 300
DE - Germania 299
RU - Federazione Russa 223
UA - Ucraina 170
FI - Finlandia 152
TR - Turchia 120
FR - Francia 114
BR - Brasile 81
BG - Bulgaria 69
IN - India 55
ID - Indonesia 43
BE - Belgio 39
CZ - Repubblica Ceca 35
CA - Canada 23
NL - Olanda 21
VN - Vietnam 20
IE - Irlanda 18
LT - Lituania 17
IR - Iran 16
KR - Corea 15
BZ - Belize 13
EU - Europa 12
JP - Giappone 12
ES - Italia 9
AT - Austria 8
CH - Svizzera 7
AU - Australia 6
MY - Malesia 6
PL - Polonia 6
SK - Slovacchia (Repubblica Slovacca) 6
BD - Bangladesh 5
DK - Danimarca 5
RO - Romania 5
AR - Argentina 4
CL - Cile 4
CO - Colombia 4
MA - Marocco 4
NO - Norvegia 4
PE - Perù 4
TW - Taiwan 4
AZ - Azerbaigian 3
GR - Grecia 3
KG - Kirghizistan 3
PA - Panama 3
PT - Portogallo 3
AE - Emirati Arabi Uniti 2
EC - Ecuador 2
EG - Egitto 2
IL - Israele 2
LB - Libano 2
MD - Moldavia 2
MX - Messico 2
OM - Oman 2
RS - Serbia 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
GY - Guiana 1
HU - Ungheria 1
IQ - Iraq 1
JO - Giordania 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
MZ - Mozambico 1
PH - Filippine 1
PK - Pakistan 1
PY - Paraguay 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 13.822
Città #
Fairfield 1.188
Southend 978
Santa Clara 822
Woodbridge 746
Ashburn 687
Chandler 591
Houston 558
Ann Arbor 455
Seattle 444
Cambridge 357
Wilmington 335
Nyköping 331
Jacksonville 328
Dearborn 317
Hong Kong 293
Singapore 256
Modena 190
London 182
New York 110
Beijing 101
Helsinki 92
San Diego 80
Fremont 73
Sofia 68
Bremen 67
Princeton 66
Eugene 63
Izmir 63
Moscow 54
Bologna 44
Jakarta 39
Milan 35
Redwood City 34
Brussels 32
Boardman 28
Council Bluffs 28
Shanghai 28
Munich 26
Des Moines 24
San Jose 19
Dallas 17
Dublin 17
Chicago 16
Dong Ket 16
Las Vegas 16
Los Angeles 16
Hefei 14
Toronto 14
Albuquerque 13
Belize City 13
Brno 12
Guangzhou 12
Kunming 12
Paris 11
Leawood 10
Rome 10
Washington 10
Kilburn 9
Nanjing 9
Pavia 9
Chiswick 8
Lauterbourg 8
Norwalk 8
San Mateo 8
Wuhan 8
Perugia 7
Saint Louis 7
San Francisco 7
Seongnam-si 7
São Paulo 7
Botucatu 6
Nanchang 6
Rimini 6
Romainville 6
Vienna 6
Bangalore 5
Bengaluru 5
Correggio 5
Frankfurt am Main 5
Nuremberg 5
Parma 5
Phoenix 5
Prescot 5
Tokyo 5
Tulare 5
Verona 5
Bari 4
Castelnuovo Rangone 4
Central 4
Chengdu 4
Columbus 4
Dhaka 4
Düsseldorf 4
Falls Church 4
Genova 4
Ghent 4
Grafing 4
Hanoi 4
Kosice 4
Ottawa 4
Totale 10.704
Nome #
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 308
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 292
Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles 280
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 269
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 268
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 265
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 263
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 260
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 254
Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients. 247
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 237
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 236
An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1-MECOM fusion transcripts 235
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 235
Acute appendicitis in adult neutropenic patients with hematologic malignancies 234
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 234
Mucorales-specific T cells in patients with hematologic malignancies 232
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 230
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 230
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 229
B cells and herpesviruses: a model of lymphoproliferation 228
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis 226
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 225
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 225
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests 224
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 222
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 220
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 219
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 216
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 216
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 214
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 210
The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes 209
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 208
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 207
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 205
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 199
How I treat HHV8/KSHV-related diseases in posttransplant patients. 197
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 196
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 196
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 195
Pain and emotional distress in leukemia patients at diagnosis. 192
Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers 192
Inflammatory myofibroblastic tumor of the bone marrow. 192
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 189
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 183
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 182
Philadelphia chromosome-positive acute lymphoblastic leukemia 179
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation 179
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout” 178
Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives 174
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. 171
Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic leukemia: a retrospective monocenter study 171
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 170
Severe pneumonia caused by Legionella pneumophila serogroup 11, Italy. 167
Splenomegaly in hematological malignancies and portal hypertension 166
Persistent hiccups as an adverse event to FLAG-IDA regimenfor leukemia. 164
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 163
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 162
"Metodo per la diagnosi e/o il monitoraggio della mucormicosi" - "Method for the diagnosis of and/or monitoring mucormycosis" 161
May the correlation between Kit-D816 mutation and AML1-ETO level change the use of prognostic factors in t(8;21) AML? 159
Acute promyelocytic leukemia in very elderly patients: still aclinical challenge. 152
Ibrutinib Is a Newly Recognized Host Factor for the Definition of Probable Invasive Pulmonary Mold Disease, Based on Off-target Effects, Unrelated to Its B-cell Immunosuppressant Activity 152
β-HHVs and HHV-8 in Lymphoproliferative Disorders. 143
Pain and emozional distress in hematological patients throughout all phases of disease: results from a multidisciplinary research team in Modena University Hospital 139
Early palliative/supportive care in acute myeloid leukaemia allows low aggression end-of-life interventions: Observational outpatient study 92
Improved efficacy of quizartinib in combination therapy with PI3K inhibition in primary FLT3-ITD AML cells 75
Edmonton symptom assessment system Global Distress Score and overall survival in acute leukaemia 66
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 63
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid Leukemia 56
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study 40
Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients 40
Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience 18
The dynamic functions of IRF4 in B cell malignancies 16
Totale 14.041
Categoria #
all - tutte 54.754
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.754


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020329 0 0 0 0 0 0 0 0 0 101 111 117
2020/20212.173 142 132 183 268 231 185 141 251 99 261 141 139
2021/20221.553 69 208 160 96 32 71 85 83 140 145 296 168
2022/20231.765 231 219 109 173 273 203 58 169 163 23 72 72
2023/20241.191 33 48 92 88 215 139 137 210 23 22 77 107
2024/20252.339 129 44 72 214 567 464 237 175 397 40 0 0
Totale 14.041